Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

29.920
-0.300-0.99%
Volume:397.01K
Turnover:11.97M
Market Cap:11.07B
PE:-1.14
High:32.360
Open:30.120
Low:29.300
Close:30.220
52wk High:50.200
52wk Low:19.600
Shares:370.00M
HK Float Shares:338.00M
Volume Ratio:1.76
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-26.205
ROE:--
ROA:-30.27%
PB:-3.69
PE(LYR):-1.14
PS:50.44

Loading ...

GenFleet (2595) Included in Key Hang Seng and MSCI Indices

Bulletin Express
·
Feb 13

GENFLEET-B (02595) Added to Hang Seng and MSCI Index Series

Stock News
·
Feb 13

GenFleet Therapeutics Joins Hang Seng and MSCI Indices

Reuters
·
Feb 13

Short Sale List Update Takes Effect Today with 51 Additions Including GenFleet-B

Stock News
·
Feb 13

GenFleet Therapeutics (Shanghai) Inc. Announces Revised Articles of Association

Bulletin Express
·
Feb 09

GenFleet (2595) Passes All Resolutions at EGM and Abolishes Supervisory Committee

Bulletin Express
·
Feb 09

GenFleet Therapeutics Held Extraordinary General Meeting

Reuters
·
Feb 09

BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks

Stock News
·
Feb 05

GenFleet Therapeutics (02595) Releases Monthly Return for January 2026

Bulletin Express
·
Feb 05

Bocom International Initiates Coverage on GENFLEET-B (02595) with Buy Rating, HK$51 Target Price

Stock News
·
Jan 23

Genfleet Therapeutics (Shanghai) Inc. Announces Date for Upcoming Extraordinary General Meeting

Reuters
·
Jan 23

GenFleet Therapeutics Shareholders to Vote on Abolishing Supervisory Committee and Amending Articles of Association

Reuters
·
Jan 20

GENFLEET-B (02595) Nears Inclusion in Stock Connect: Stable Trading as Key Factor

Stock News
·
Dec 11, 2025

GENFLEET-B (02595): GFH375 Phase III Trial for Metastatic Pancreatic Cancer Initiated at First Site – World’s First Oral KRAS G12D Inhibitor Monotherapy vs. Chemotherapy Study

Stock News
·
Dec 05, 2025

GenFleet Therapeutics Launches Phase III Trial of Oral KRAS G12D Inhibitor for Metastatic Pancreatic Cancer

Reuters
·
Dec 05, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025

GENFLEET-B (02595) Proposes Adoption of H Share Option Scheme and H Share Incentive Plan

Stock News
·
Nov 24, 2025

HK Stock Movement | GENFLEET-B (02595) Surges Over 8% in Late Trading as GFH375 Tablets Enter Phase III Clinical Trial for Metastatic Pancreatic Cancer

Stock News
·
Nov 13, 2025

HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 9%

Tiger Newspress
·
Nov 10, 2025

Hong Kong Stock Movement | GENFLEET-B (02595) Recovers Over 9% After Completion of First Patient Enrollment in GFH375 Combination Therapy for Advanced Solid Tumors

Stock News
·
Oct 23, 2025